Literature DB >> 20177771

Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update.

Aboubakr M Elnashar1.   

Abstract

Premature luteinization (PL) refers to a rise in serum progesterone (P) levels on the day of hCG administration. Most studies used an absolute P level on the day of hCG administration as an indicator of PL, and the cutoff level differed from 0.8 to 2 ng/mL. Some authors defined PL as a P/E2 ratio of >1. There is a marked variation in the incidence (13% to 71%), of PL due to discrepancies in definition, population characteristics and/or treatment protocols. The pathogenesis of PL in COH is still poorly understood. Several hypotheses may be considered to explain this phenomenon: elevation of follicular LH levels, serum accumulation of HCG from HMG, increased LH receptor sensitivity of the granulosa cells to FSH, or poor ovarian response with increased LH sensitivity. The consequences of this premature elevation of serum P on IVF outcome remain controversial. Attempts to prevent COH include: use of Low-dose hCG alone in the late COH stages, flexible antagonist protocol, use of mifepristone, aspiration of a single leading follicle, hCG administration when the levels of serum P exceeded 1.0 ng/mL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177771      PMCID: PMC2854984          DOI: 10.1007/s10815-010-9393-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  68 in total

1.  Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture.

Authors:  R Fanchin; A Hourvitz; F Olivennes; J Taieb; A Hazout; R Frydman
Journal:  Fertil Steril       Date:  1997-10       Impact factor: 7.329

2.  Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007).

Authors:  Ernesto Bosch
Journal:  Hum Reprod Update       Date:  2008-01-28       Impact factor: 15.610

3.  Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle P rise.

Authors:  T Harada; C Katagiri; N Takao; T Toda; Y Mio; N Terakawa
Journal:  Fertil Steril       Date:  1996-03       Impact factor: 7.329

4.  Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer.

Authors:  M Bustillo; J J Stern; C B Coulam
Journal:  Hum Reprod       Date:  1995-11       Impact factor: 6.918

Review 5.  Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis.

Authors:  C A Venetis; E M Kolibianakis; E Papanikolaou; J Bontis; P Devroey; B C Tarlatzis
Journal:  Hum Reprod Update       Date:  2007-04-03       Impact factor: 15.610

6.  Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles.

Authors:  F Ubaldi; C Albano; M Peukert; H Riethmuller-Winzen; M Camus; J Smitz; A Van Steirteghem; P Devroey
Journal:  Hum Reprod       Date:  1996-07       Impact factor: 6.918

7.  Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort.

Authors:  D V Moffitt; J T Queenan; R Shaw; S J Muasher
Journal:  Fertil Steril       Date:  1997-02       Impact factor: 7.329

8.  Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone.

Authors:  F Ubaldi; J Smitz; A Wisanto; H Joris; J Schiettecatte; M P Derde; E Borkham; A Van Steirteghem; P Devroey
Journal:  Hum Reprod       Date:  1995-12       Impact factor: 6.918

9.  Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.

Authors:  Yu-Che Ou; Kuo-Chung Lan; Shiuh-Young Chang; Fu-Tsai Kung; Fu-Jen Huang
Journal:  Taiwan J Obstet Gynecol       Date:  2008-06       Impact factor: 1.705

10.  Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.

Authors:  Kok-Min Seow; Yu-Hung Lin; Lee-Win Huang; Bih-Chwen Hsieh; Shih-Chia Huang; Chin-Yu Chen; Pei-Hsin Chen; Chii-Ruey Tzeng; Jiann-Loong Hwang
Journal:  Gynecol Endocrinol       Date:  2007-06       Impact factor: 2.260

View more
  24 in total

1.  Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome.

Authors:  Cuiying Peng; Zifen Guo; Xingyu Long; Guangxiu Lu
Journal:  J Assist Reprod Genet       Date:  2012-05-03       Impact factor: 3.412

2.  A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles.

Authors:  L A Kondapalli; T A Molinaro; M D Sammel; A Dokras
Journal:  Hum Reprod       Date:  2012-06-29       Impact factor: 6.918

3.  Ovarian reserve status in young women is associated with altered gene expression in membrana granulosa cells.

Authors:  Christine C Skiadas; Shenghua Duan; Mick Correll; Renee Rubio; Nilay Karaca; Elizabeth S Ginsburg; John Quackenbush; Catherine Racowsky
Journal:  Mol Hum Reprod       Date:  2012-02-20       Impact factor: 4.025

4.  Are extremely high progesterone levels still an issue in IVF?

Authors:  V S Vanni; P Viganò; L Quaranta; L Pagliardini; P Giardina; M Molgora; M Munaretto; M Candiani; E Papaleo
Journal:  J Endocrinol Invest       Date:  2016-08-27       Impact factor: 4.256

5.  A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome.

Authors:  Fei Gong; Xihong Li; Shunji Zhang; Hainan Ma; Sufen Cai; Juan Li; G E Lin; Guangxiu Lu
Journal:  Exp Ther Med       Date:  2015-09-23       Impact factor: 2.447

6.  The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles - a randomized controlled study.

Authors:  Ashraf Moini; Shahrzad Zadeh Modarress; Elham Amirchaghmaghi; Naeimeh Mirghavam; Soraya Khafri; Mohammad Reza Akhoond; Reza Salman Yazdi
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

7.  Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles.

Authors:  Ju Hee Park; Byung Chul Jee; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2015-06-30

8.  Premature progesterone rise at human chorionic gonadotropin triggering day has no correlation with intracytoplasmic sperm injection outcome.

Authors:  Nasrin Saharkhiz; Saghar Salehpour; Mahboobeh Tavasoli; Ali Aghighi
Journal:  Iran J Reprod Med       Date:  2015-02

9.  Progesterone/Estradiol Ratio as a Predictor in the ART Cycles with Premature Progesterone Elevation on the Day of hCG Trigger.

Authors:  Mariano Mascarenhas; Mohan Shashikant Kamath; Achamma Chandy; Aleyamma T Kunjummen
Journal:  J Reprod Infertil       Date:  2015 Jul-Sep

10.  Effect of progesterone supplementation on natural frozen-thawed embryo transfer cycles: a randomized controlled trial.

Authors:  Maryam Eftekhar; Mozhgan Rahsepar; Elham Rahmani
Journal:  Int J Fertil Steril       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.